Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1996;94:432-436

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zuanetti, G.
Right arrow Articles by Ewing, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zuanetti, G.
Right arrow Articles by Ewing, D. J.

(Circulation. 1996;94:432-436.)
© 1996 American Heart Association, Inc.


Articles

Prognostic Significance of Heart Rate Variability in Post–Myocardial Infarction Patients in the Fibrinolytic Era

The GISSI-2 Results

Giulio Zuanetti, MD; James M.M. Neilson, PhD; Roberto Latini, MD; Eugenio Santoro, BS; Aldo P. Maggioni, MD; David J. Ewing, MD; on Behalf of GISSI-2 Investigators*1

the University Departments of Medicine and Medical Physics and Medical Engineering, Royal Infirmary, Edinburgh, Scotland (J.M.M.N., D.J.E.), and the GISSI-2 Coordinating Center, Milano, Italy.

Correspondence to Giulio Zuanetti, MD, GISSI-2 Coordinating Center, Istituto Mario Negri, via Eritrea, 62, 20157 Milano, Italy. E-mail zuanetti@irfmn.mnegri.it.

Background Studies performed before the introduction of fibrinolysis showed that a low heart rate variability (HRV) is associated with higher mortality in post–myocardial infarction (MI) patients. We evaluated whether HRV adds information relevant to risk stratification in patients treated with fibrinolysis as well.

Methods and Results From 24-hour ECG recordings obtained at discharge in patients treated with recombinant tissue-type plasminogen activator or streptokinase, we measured several time-domain indexes of HRV: standard deviation (SDNN), root-mean-square of successive differences (RMSSD), and number of RR interval increases >50 ms ("NN50+"). The prognostic value of HRV for total and cardiovascular mortality was assessed. Of 567 patients with valid recordings, 52 (9.1%) died during the 1000 days of follow-up, 44 (7.8%) of cardiovascular causes. All indexes of low HRV were able to identify patients (16% to 18% of total population) with a higher total mortality (20.8% to 24.2% versus 6.0% to 6.8%, depending on index used). The independent predictive value of low HRV was confirmed by the adjusted analysis with the following relative risks: NN50+, 3.5 (95% CI, 1.9 to 6.7); SDNN, 3.0 (95% CI, 1.55 to 5.9); and RMSSD, 2.8 (95% CI, 1.5 to 5.3). Advanced age, previous MI, Killip class at entry, and use of digitalis were also independent predictors. Similar data were obtained for cardiovascular mortality.

Conclusions Time-domain indexes of HRV retain their independent prognostic significance even in post-MI patients of all ages treated with fibrinolysis.


Key Words: heart rate • myocardial infarction • fibrinolysis • prognosis • electrocardiography




This article has been cited by other articles:


Home page
Am J Crit CareHome page
C. J. Kirkness, R. L. Burr, and P. H. Mitchell
Intracranial and Blood Pressure Variability and Long-Term Outcome After Aneurysmal Sub-arachnoid Hemorrhage
Am. J. Crit. Care., May 1, 2009; 18(3): 241 - 251.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
H. V Huikuri, J. S Perkiomaki, R. Maestri, and G. D. Pinna
Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics
Phil Trans R Soc A, April 13, 2009; 367(1892): 1223 - 1238.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Kikuya, T. Ohkubo, H. Metoki, K. Asayama, A. Hara, T. Obara, R. Inoue, H. Hoshi, J. Hashimoto, K. Totsune, et al.
Day-by-Day Variability of Blood Pressure and Heart Rate at Home as a Novel Predictor of Prognosis: The Ohasama Study
Hypertension, December 1, 2008; 52(6): 1045 - 1050.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
V. Vaccarino, R. Lampert, J. D. Bremner, F. Lee, S. Su, C. Maisano, N. V. Murrah, L. Jones, F. Jawed, N. Afzal, et al.
Depressive Symptoms and Heart Rate Variability: Evidence for a Shared Genetic Substrate in a Study of Twins
Psychosom Med, July 1, 2008; 70(6): 628 - 636.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
T. Laitio, J. Jalonen, T. Kuusela, and H. Scheinin
The Role of Heart Rate Variability in Risk Stratification for Adverse Postoperative Cardiac Events
Anesth. Analg., December 1, 2007; 105(6): 1548 - 1560.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
HeartHome page
G A Lanza, D Cianflone, A G Rebuzzi, G Angeloni, A Sestito, G Ciriello, G La Torre, F Crea, A Maseri, and for the Stratificazione Prognostica dell'Angina In
Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina
Heart, August 1, 2006; 92(8): 1055 - 1063.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. H. Makikallio, P. Barthel, R. Schneider, A. Bauer, J. M. Tapanainen, M. P. Tulppo, G. Schmidt, and H. V. Huikuri
Prediction of sudden cardiac death after acute myocardial infarction: role of Holter monitoring in the modern treatment era
Eur. Heart J., April 2, 2005; 26(8): 762 - 769.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. M. Makikallio, T. H. Makikallio, J. T. Korpelainen, K. A. Sotaniemi, H. V. Huikuri, and V. V. Myllyla
Heart rate dynamics predict poststroke mortality
Neurology, May 25, 2004; 62(10): 1822 - 1826.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. H. Hohnloser and B. J. Gersh
Changing Late Prognosis of Acute Myocardial Infarction: Impact on Management of Ventricular Arrhythmias in the Era of Reperfusion and the Implantable Cardioverter-Defibrillator
Circulation, February 25, 2003; 107(7): 941 - 946.
[Full Text] [PDF]


Home page
HeartHome page
J E Mietus, C-K Peng, I Henry, R L Goldsmith, and A L Goldberger
The pNNx files: re-examining a widely used heart rate variability measure
Heart, October 1, 2002; 88(4): 378 - 380.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, J. A. Camm, R. Cappato, S. M. Cobbe, C. Di Mario, et al.
TASK FORCE ON SUDDEN CARDIAC DEATH, EUROPEAN SOCIETY OF CARDIOLOGY: Summary of Recommendations
Europace, January 1, 2002; 4(1): 3 - 18.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. D Struthers
Review: Aldosterone-induced vasculopathy: a new reversible cause of cardiac death
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2001; 2(4): 211 - 214.
[PDF]


Home page
J Am Coll CardiolHome page
J. J. Bailey, A. S. Berson, H. Handelsman, and M. Hodges
Utility of current risk stratification tests for predicting major arrhythmic events after myocardial infarction
J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1902 - 1911.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
H. V. Huikuri, A. Castellanos, and R. J. Myerburg
Sudden Death Due to Cardiac Arrhythmias
N. Engl. J. Med., November 15, 2001; 345(20): 1473 - 1482.
[Full Text] [PDF]


Home page
Eur Heart JHome page
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al.
Task Force on Sudden Cardiac Death of the European Society of Cardiology
Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450.
[PDF]


Home page
J Am Coll CardiolHome page
P. Gaudron, I. Kugler, K. Hu, W. Bauer, C. Eilles, and G. Ertl
Time course of cardiac structural, functional and electrical changes in asymptomatic patients after myocardial infarction: their inter-relation and prognostic impact
J. Am. Coll. Cardiol., July 1, 2001; 38(1): 33 - 40.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
F. Lombardi, T. H Makikallio, R. J Myerburg, and H. V Huikuri
Sudden cardiac death: role of heart rate variability to identify patients at risk
Cardiovasc Res, May 1, 2001; 50(2): 210 - 217.
[Full Text] [PDF]


Home page
HypertensionHome page
O. Baltatu, B. J. Janssen, G. Bricca, R. Plehm, J. Monti, D. Ganten, and M. Bader
Alterations in Blood Pressure and Heart Rate Variability in Transgenic Rats With Low Brain Angiotensinogen
Hypertension, February 1, 2001; 37(2): 408 - 413.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Kornitzer
Predictive value of electrocardiographic markers for autonomic nervous system dysfunction in healthy populations: more studies needed
Eur. Heart J., January 2, 2001; 22(2): 109 - 112.
[PDF]


Home page
HypertensionHome page
M. Kikuya, A. Hozawa, T. Ohokubo, I. Tsuji, M. Michimata, M. Matsubara, M. Ota, K. Nagai, T. Araki, H. Satoh, et al.
Prognostic Significance of Blood Pressure and Heart Rate Variabilities : The Ohasama Study
Hypertension, November 1, 2000; 36(5): 901 - 906.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. Malik, A. J. Camm, M. J. Janse, D. G. Julian, G. A. Frangin, P. J. Schwartz, and on behalf of the EMIAT Investigators
Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial)
J. Am. Coll. Cardiol., April 1, 2000; 35(5): 1263 - 1275.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. V. Huikuri, T. H. Makikallio, C.-K. Peng, A. L. Goldberger, U. Hintze, and M. Moller
Fractal Correlation Properties of R-R Interval Dynamics and Mortality in Patients With Depressed Left Ventricular Function After an Acute Myocardial Infarction
Circulation, January 4, 2000; 101(1): 47 - 53.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. V. Huikuri, T. Makikallio, K. E. J. Airaksinen, R. Mitrani, A. Castellanos, and R. J. Myerburg
Measurement of heart rate variability: a clinical tool or a research toy?
J. Am. Coll. Cardiol., December 1, 1999; 34(7): 1878 - 1883.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. H. Hohnloser, T. Klingenheben, M. Zabel, M. Schopperl, and O. Mauss
Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era
J. Am. Coll. Cardiol., June 1, 1999; 33(7): 1895 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. J. Goldberger
Sympathovagal balance: how should we measure it?
Am J Physiol Heart Circ Physiol, April 1, 1999; 276(4): H1273 - H1280.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Nolan, P. D. Batin, R. Andrews, S. J. Lindsay, P. Brooksby, M. Mullen, W. Baig, A. D. Flapan, A. Cowley, R. J. Prescott, et al.
Prospective Study of Heart Rate Variability and Mortality in Chronic Heart Failure : Results of the United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-Heart)
Circulation, October 13, 1998; 98(15): 1510 - 1516.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Zabel, T. Klingenheben, M. R. Franz, and S. H. Hohnloser
Assessment of QT Dispersion for Prediction of Mortality or Arrhythmic Events After Myocardial Infarction : Results of a Prospective, Long-term Follow-up Study
Circulation, June 30, 1998; 97(25): 2543 - 2550.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. W. Nesto and S. Zarich
Acute Myocardial Infarction in Diabetes Mellitus : Lessons Learned From ACE Inhibition
Circulation, January 13, 1998; 97(1): 12 - 15.
[Full Text] [PDF]


Home page
CirculationHome page
L. Tavazzi and A. Volpi
Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials
Circulation, March 4, 1997; 95(5): 1341 - 1345.
[Full Text]